Respiratory Biologics Have Significantly Reduced Asthma Exacerbations
A large-scale study finds that the introduction of asthma biologics in 2015 has led to immediate and sustained reductions in exacerbations at the population level.
A large-scale study finds that the introduction of asthma biologics in 2015 has led to immediate and sustained reductions in exacerbations at the population level.
Integrating genetic and telomere assessments into clinical care helps physicians refine diagnoses and adjust pulmonary fibrosis treatment plans.
Experts and healthcare organizations gathered in Germany for the 9th World Bronchiectasis Conference to share updates on clinical care, research findings, and new digital resources.
Researchers suggest delivering vitamin D directly to the lungs could bypass the limitations of oral supplements in treating COPD and asthma.
AERO-007 demonstrated significant lung function improvements over 24 hours in patients with moderate-to-severe COPD.
Combining formoterol and methacholine significantly improves mucociliary clearance in animal models of cystic fibrosis, compared to using either drug alone.
Phase 3 trial results show significant reductions in clinical worsening and acute exacerbations for patients with idiopathic pulmonary fibrosis (IPF).
New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.
Researchers linked loss-of-function variants in the TMEM63B gene to a novel disorder causing interstitial lung disease in some pediatric patients.